Real-time enrollment status for this nsclc adenocarcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:06 PM UTC
| NCT Number | NCT07277413 |
| Recruiting Status | Recruiting |
| Condition | NSCLC Adenocarcinoma |
| Phase | PHASE1 |
| Target Enrollment | 260 participants |
| Active Locations | 23 sites in the US |
| Sponsor | IDEAYA Biosciences |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT07277413 is currently recruiting participants. This phase1 study for nsclc adenocarcinoma is actively seeking new participants at 23 locations across the United States. The study is sponsored by IDEAYA Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07277413 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07277413 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.